Item 7.01. Regulation FD Disclosure.
On
The information in this Item 7.01 and in the press release attached as
Exhibit 99.1 to this Current Report on Form 8-K shall not be deemed to be
"filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended, or otherwise subject to the liabilities of that section or Sections 11
and 12(a)(2) of the Securities Act of 1933, as amended. The information
contained in this Item 7.01 and in the press release attached as Exhibit 99.1 to
this Current Report on Form 8-K shall not be incorporated by reference into any
filing with the
The press release attached as Exhibit 99.1 to this Current Report on Form 8-K includes "safe harbor" language pursuant to the Private Securities Litigation Reform Act of 1995, as amended, indicating that certain statements contained therein are "forward-looking" rather than historical.
The Company undertakes no duty or obligation to update or revise the information
contained in this Current Report on Form 8-K, although it may do so from time to
time if its management believes it is appropriate. Any such updating may be made
through the filing of other reports or documents with the
Item 8.01. Other Events
On
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. Exhibit Number Description 99.1iBio, Inc. Press Release datedJanuary 25, 2022 104 Cover Page Interactive Data File (embedded within the XBRL document)
© Edgar Online, source